Patients disposition and baseline characteristics
DYSFUNCTION
Overall, 100 patients were included and 93 were randomized and used the allocated study device (ITT Population): 45 patients in the Omnipod group and 48 patients in the A7+TouchCare group. Among them, 78 completed the study: 43 (95.6%) in the Omnipod group and 35 (72.9%) in the A7+Touchcare group. The main reasons for premature study withdrawal were the Covid-19 context (4 patients ended the study because of the COVID-19 context and one withdrew consent), intolerance (4 patients), device dysfunction (3 patients), consent withdrawal (1 patient), or another reason (2 patients). The PP population was therefore composed of 78 patients (43 patients in the Omnipod group and 35 patients in the A7+TouchCare group). The mITT population was composed of 89 patients (45 in the Omnipod group and 44 in the A7+TouchCare group). (